{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T15:38:11Z","timestamp":1778859491326,"version":"3.51.4"},"reference-count":42,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,3,8]],"date-time":"2019-03-08T00:00:00Z","timestamp":1552003200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2019.00428","type":"journal-article","created":{"date-parts":[[2019,3,8]],"date-time":"2019-03-08T04:19:10Z","timestamp":1552018750000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":19,"title":["HLA Class II Genes HLA-DRB1, HLA-DPB1, and HLA-DQB1 Are Associated With the Antibody Response to Inactivated Japanese Encephalitis Vaccine"],"prefix":"10.3389","volume":"10","author":[{"given":"Yufeng","family":"Yao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huijuan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuyuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chuanying","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ziyun","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mingbo","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2019,3,8]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/21645515.2017.1285472","article-title":"Japanese encephalitis vaccines: Immunogenicity, protective efficacy, effectiveness, and impact on the burden of disease","volume":"13","author":"Hegde","year":"2017","journal-title":"Hum Vaccin Immunother"},{"key":"B2","doi-asserted-by":"publisher","first-page":"766","DOI":"10.2471\/BLT.10.085233","article-title":"Estimated global incidence of Japanese encephalitis: a systematic review","volume":"89","author":"Campbell","year":"2011","journal-title":"Bull World Health Organ"},{"key":"B3","first-page":"658","article-title":"Japanese encephalitis surveillance and immunization\u2013Asia and the Western Pacific, 2012","volume":"62","year":"2013","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"B4","doi-asserted-by":"publisher","first-page":"2","DOI":"10.4172\/2157-2526.S1-002","article-title":"Japanese encephalitis vaccines","volume":"1","author":"McArthur","year":"2011","journal-title":"J Bioterror BiodefS"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1586\/erv.09.112","article-title":"Ixiaro: a new vaccine against Japanese encephalitis","volume":"8","author":"Jelinek","year":"2009","journal-title":"Expert Rev Vaccines"},{"key":"B6","doi-asserted-by":"publisher","first-page":"263","DOI":"10.4161\/hv.26902","article-title":"Japanese encephalitis: the virus and vaccines","volume":"10","author":"Yun","year":"2014","journal-title":"Hum Vaccin Immunother"},{"key":"B7","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/S0264-410X(00)00038-4","article-title":"Points to consider in the development of a surrogate for efficacy of novel Japanese encephalitis virus vaccines","volume":"18","author":"Markoff","year":"2000","journal-title":"Vaccine"},{"key":"B8","doi-asserted-by":"publisher","first-page":"5925","DOI":"10.1016\/j.vaccine.2011.06.062","article-title":"Correlation of protection against Japanese encephalitis virus and JE vaccine (IXIARO\u00ae;) induced neutralizing antibody titers","volume":"29","author":"Van Gessel","year":"2011","journal-title":"Vaccine"},{"key":"B9","doi-asserted-by":"publisher","first-page":"e3015","DOI":"10.1371\/journal.pntd.0003015","article-title":"Vaccine strategies for the control and prevention of Japanese encephalitis in Mainland China, 1951-2011","volume":"8","author":"Gao","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"key":"B10","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1517\/14712590903042282","article-title":"IC51 Japanese encephalitis vaccine","volume":"9","author":"Kollaritsch","year":"2009","journal-title":"Expert Opin Biol Ther"},{"key":"B11","first-page":"643","article-title":"The efficacy of Japanese encephalitis vaccine in Henan, China: a case-control study","volume":"25","author":"Luo","year":"1994","journal-title":"Southeast Asian J Trop Med Public Health"},{"key":"B12","doi-asserted-by":"publisher","first-page":"2259","DOI":"10.1016\/S0264-410X(99)00006-7","article-title":"Primary and booster immune responses to SA14-14-2 Japanese encephalitis vaccine in Korean infants","volume":"17","author":"Sohn","year":"1999","journal-title":"Vaccine"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1016\/S0140-6736(05)67567-8","article-title":"Effect of single dose of SA 14-14-2 vaccine 1 year after immunisation in Nepalese children with Japanese encephalitis: a case-control study","volume":"366","author":"Ohrr","year":"2005","journal-title":"Lancet"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1007\/s13312-013-0292-9","article-title":"Indian Academy of Pediatrics (IAP) recommended immunization schedule for children aged 0 through 18 years, India, 2013 and updates on immunization","volume":"50","author":"Vashishtha","year":"2013","journal-title":"Indian Pediatr"},{"key":"B15","doi-asserted-by":"publisher","first-page":"3840","DOI":"10.1002\/(SICI)1521-4141(199811)28:11<3840::AID-IMMU3840>3.0.CO;2-T","article-title":"Naturally processed peptides from HLA-DQ7 (alpha1*0501-beta1*0301): influence of both alpha and beta chain polymorphism in the HLA-DQ peptide binding specificity","volume":"28","author":"Khalil-Daher","year":"1998","journal-title":"Eur J Immunol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1056\/NEJM200009073431006","article-title":"The HLA system. First of two parts.","volume":"343","author":"Klein","year":"2000","journal-title":"N Engl J Med"},{"key":"B17","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1086\/427558","article-title":"Human leukocyte antigen class II alleles and rubella-specific humoral and cell-mediated immunity following measles-mumps-rubella-II vaccination","volume":"191","author":"Ovsyannikova","year":"2005","journal-title":"J Infect Dis"},{"key":"B18","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1586\/14760584.5.1.33","article-title":"Human leukocyte antigen polymorphisms: variable humoral immune responses to viral vaccines","volume":"5","author":"Ovsyannikova","year":"2006","journal-title":"Expert Rev Vaccines"},{"key":"B19","first-page":"170","volume-title":"Japanese Encephalitis Vaccine(Vero Cell), Inactivated, Freeze-dried","year":"2015"},{"key":"B20","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s12859-017-1496-0","article-title":"PyHLA: tests for the association between HLA alleles and diseases","volume":"18","author":"Fan","year":"2017","journal-title":"BMC Bioinformatics"},{"key":"B21","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1111\/j.1399-0039.2006.00769.x","article-title":"PyPop update\u2013a software pipeline for large-scale multilocus population genomics","volume":"69","author":"Lancaster","year":"2007","journal-title":"Tissue Antigens"},{"key":"B22","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1142\/9789812776303_0048","article-title":"PyPop: a software framework for population genomics: analyzing large-scale multi-locus genotype data","volume":"8","author":"Lancaster","year":"2003","journal-title":"Pac Symp Biocomput"},{"key":"B23","doi-asserted-by":"publisher","first-page":"361","DOI":"10.2307\/2532296","article-title":"Performing the exact test of Hardy-Weinberg proportion for multiple alleles","volume":"48","author":"Guo","year":"1992","journal-title":"Biometrics"},{"key":"B24","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1089\/omi.2011.0032","article-title":"Vaccinomics and a new paradigm for the development of preventive vaccines against viral infections","volume":"15","author":"Poland","year":"2011","journal-title":"OMICS"},{"key":"B25","doi-asserted-by":"publisher","first-page":"12300","DOI":"10.1073\/pnas.1400476111","article-title":"Systems vaccinology: probing humanity's diverse immune systems with vaccines","volume":"111","author":"Pulendran","year":"2014","journal-title":"Proc Natl Acad Sci USA"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1016\/j.vaccine.2018.01.069","article-title":"RTS,S malaria vaccine efficacy and immunogenicity during Plasmodium falciparum. challenge is associated with HLA genotype.","volume":"36","author":"Nielsen","year":"2018","journal-title":"Vaccine"},{"key":"B27","first-page":"233","article-title":"Human leukocyte antigens influence the antibody response to hepatitis B vaccine","volume":"14","author":"Jafarzadeh","year":"2015","journal-title":"Iran J Allergy Asthma Immunol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"2457","DOI":"10.1016\/j.vaccine.2017.03.021","article-title":"Minimal association of alleles of human leukocyte antigen class II gene and long-term antibody response to hepatitis B vaccine vaccinated during infancy","volume":"35","author":"Xu","year":"2017","journal-title":"Vaccine"},{"key":"B29","doi-asserted-by":"publisher","first-page":"e0171261","DOI":"10.1371\/journal.pone.0171261","article-title":"A large population-based association study between HLA and KIR genotypes and measles vaccine antibody responses","volume":"12","author":"Ovsyannikova","year":"2017","journal-title":"PLoS ONE"},{"key":"B30","doi-asserted-by":"publisher","first-page":"2146","DOI":"10.1016\/j.vaccine.2012.01.038","article-title":"Consistency of HLA associations between two independent measles vaccine cohorts: a replication study","volume":"30","author":"Ovsyannikova","year":"2012","journal-title":"Vaccine"},{"key":"B31","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/S0264-410X(98)00203-5","article-title":"Human leukocyte antigens influence the immune response to a pre-S\/S hepatitis B vaccine","volume":"17","author":"McDermott","year":"1999","journal-title":"Vaccine"},{"key":"B32","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/S0264-410X(01)00346-2","article-title":"Identification of an association between HLA class II alleles and low antibody levels after measles immunization","volume":"20","author":"Poland","year":"2001","journal-title":"Vaccine"},{"key":"B33","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1111\/j.1399-0039.1998.tb03001.x","article-title":"Response to hepatitis B vaccine: multiple HLA genes are involved","volume":"51","author":"Desombere","year":"1998","journal-title":"Tissue Antigens"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1016\/j.vaccine.2014.01.057","article-title":"The link between genetic variation and variability in vaccine responses: systematic review and meta-analyses","volume":"32","author":"Posteraro","year":"2014","journal-title":"Vaccine"},{"key":"B35","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1007\/s00251-004-0756-0","article-title":"HLA class II alleles and measles virus-specific cytokine immune response following two doses of measles vaccine","volume":"56","author":"Ovsyannikova","year":"2005","journal-title":"Immunogenetics"},{"key":"B36","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.gene.2018.01.053","article-title":"Fine-mapping analysis of the MHC region for vitiligo based on a new Han-MHC reference panel","volume":"648","author":"Yang","year":"2018","journal-title":"Gene"},{"key":"B37","doi-asserted-by":"publisher","first-page":"2690","DOI":"10.2337\/dc12-0312","article-title":"Immune response of hepatitis B vaccine among persons with diabetes: a systematic review of the literature","volume":"35","author":"Schillie","year":"2012","journal-title":"Diabetes Care"},{"key":"B38","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1038\/nri3084","article-title":"Towards a systems understanding of MHC class I and MHC class II antigen presentation","volume":"11","author":"Neefjes","year":"2011","journal-title":"Nat Rev Immunol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"4189","DOI":"10.4049\/jimmunol.1001006","article-title":"Divergent motifs but overlapping binding repertoires of six HLA-DQ molecules frequently expressed in the worldwide human population","volume":"185","author":"Sidney","year":"2010","journal-title":"J Immunol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1016\/j.coi.2005.07.012","article-title":"Immunogenetics of viral infections","volume":"17","author":"Martin","year":"2005","journal-title":"Curr Opin Immunol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1111\/j.1399-0039.2011.01770.x","article-title":"On the future of HLA","volume":"78","author":"Thorsby","year":"2011","journal-title":"Tissue Antigens"},{"key":"B42","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1038\/nature03113","article-title":"Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HL","volume":"432","author":"Kiepiela","year":"2004","journal-title":"Nature"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.00428\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,3,8]],"date-time":"2019-03-08T04:19:13Z","timestamp":1552018753000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.00428\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,8]]},"references-count":42,"alternative-id":["10.3389\/fimmu.2019.00428"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2019.00428","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,8]]},"article-number":"428"}}